Imaging Simplified

14 Must-Haves for Med School Students and Programs Evaluating Ultrasound Machines

This quick resource offers some essential must-haves for selecting the right handheld device to make learning faster and more effective.

Are You Looking to Conduct POCUS Research? Exo is Looking to Partner

Geisinger Improves Ultrasound Documentation Time and Billed Volume

In addition to streamlining the use of POCUS at their facilities, Geisinger has also seen an accelerated rate of completed POCUS documentation.

Revolution in Real Time: Exo Introduces SweepAI™ — Ultrasound Just Got Smarter

Exo announces the launch of SweepAI™ — a game-changing innovation in ultrasound. SweepAI, now FDA-cleared, brings intelligent cardiac and lung scanning to the Exo Iris®. This advanced AI offers instant feedback as a user sweeps through an organ, automatically identifying optimal imaging and using the scan session data to give you diagnostic insights — all in real-time, and without internet or cloud reliance.

Assessment of an Artificial Intelligence Tool for Estimating LVEF in Echocardiograms

Assessment of an Artificial Intelligence Tool for Estimating LVEF in Echocardiograms

Published in the healthcare journal, Diagnotics, the authors of this article shared the following abstract: This work aims to evaluate the performance of a new artificial intelligence tool (Exo AI) to compute the left ventricular ejection fraction (LVEF) in echocardiograms of the apical and parasternal long axis (PLAX) views. We retrospectively gathered echocardiograms from 441 individual patients (70% male, age: 67.3 ± 15.3, weight: 87.7 ± 25.4, BMI: 29.5 ± 7.4) and computed the ejection fraction in each echocardiogram using the ExoAI algorithm. We compared its performance against the ejection fraction from the clinical report. ExoAI achieved a root mean squared error of 7.58% in A2C, 7.45% in A4C, and 7.29% in PLAX, and correlations of 0.79, 0.75, and 0.89, respectively. As for the detection of low EF values (EF < 50%), ExoAI achieved an accuracy of 83% in A2C, 80% in A4C, and 91% in PLAX. Our results suggest that ExoAI effectively estimates the LVEF and it is an effective tool for estimating abnormal ejection fraction values (EF < 50%). Importantly, the PLAX view allows for the estimation of the ejection fraction when it is not feasible to acquire apical views (e.g., in ICU settings where it is not possible to move the patient to obtain an apical scan).

Is POCUS Cost Effective?

Are POCUS devices worth it from a financial standpoint? Point-of-care ultrasound devices are cost-effective for medical facilities and patients alike.

Are Handheld Ultrasounds Accurate?

Portable ultrasounds are a catalyst for retrieving a faster and more accurate diagnosis for all patients and are highly accurate when applied to the correct use cases.

What Does a Handheld Ultrasound Do?

A handheld ultrasound machine falls under the umbrella of POCUS. It can be carried in one hand and placed in a caregiver’s pocket when not used. This portability allows physicians and nurses to scan patients.

POCUS AI Helps Diagnose Heart Failure

ROI Potential with Ultrasound AI

As ultrasound AI technology advances, it could improve diagnostic accuracy, enhance operational efficiency and ultimately deliver a return on investment (ROI).

What Are the Pros and Cons of Ultrasound AI?

Ultrasound technology has revolutionized diagnostic accuracy, efficiency, and patient outcomes, and the advent of artificial intelligence (AI) is expected to accelerate this revolution. Ultrasound AI presents both benefits and challenges.

Integrating the POCUS Ecosystem: Best Practices for Enhancing Your Health System

Discover actionable insights for designing, building, and integrating a POCUS program that recoups your investment and fits seamlessly within your healthcare organization’s workflow.

Exo Introduces Exo Works® Connect to Deploy POCUS Programs in Days

New Exo Works tailored package allows POCUS clinical and educational programs to get up and running with minimal IT effort

Five Ultrasound AI Uses in Healthcare Today

Exciting new advancements in ultrasound AI are further revolutionizing the industry.

Exo® Wins “Best New Ultrasound Technology Solution” in 2024 MedTech Breakthrough Awards

Exo® has been selected as winner of the “Best New Ultrasound Technology Solution” award in the eighth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough.

Wellstar MCG Health Increases Revenue Capture by 47%

Wellstar MCG Health implemented Exo Works®, Exo’s point-of-care ultrasound (POCUS) workflow solution, to accelerate patient care and streamline exam documentation, quality assurance (QA), regulatory compliance, and revenue capture at the medical facility.

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure

Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound device.

Top 25 CFO's of San Francisco for 2024

The Evolution of Ultrasound Technology From A-Mode to POCUS AI

Ultrasound technology has become integral to modern medicine, allowing physicians and healthcare professionals to see inside the human body quickly and conveniently without invasive procedures. From modest origins to today's sophistication and a future filled with potential for ultrasound AI, ultrasound's evolution into one of the world's most prevalent medical tools encompasses numerous innovations and transformative breakthroughs.